Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
Drug nanoformulations hold remarkable promise for the efficient delivery of therapeutics to a disease site. Unfortunately, artificial nanocarriers, mostly liposomes and polymeric nanoparticles, show limited applications due to the unfavorable pharmacokinetics and rapid clearance from the blood circu...
Main Authors: | Natalia L. Klyachko, Camryn J. Arzt, Samuel M. Li, Olesia A. Gololobova, Elena V. Batrakova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/12/1171 |
Similar Items
-
Extracellular vesicle-based drug delivery systems in cancer
by: Ruotong Huang, et al.
Published: (2024-12-01) -
Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics
by: Chao Liu, et al.
Published: (2017-11-01) -
Aptamer‐based extracellular vesicle isolation, analysis and therapeutics
by: Lin Zhu, et al.
Published: (2023-04-01) -
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
by: Yuling Zhao, et al.
Published: (2022-06-01) -
Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments
by: Leila Bahmani, et al.
Published: (2022-06-01)